GlassScriptPhysician profile
Patricia D Brands
NPI 1780099721
$3,965.05
in general payments reported to CMS, 2019-2025
36 companies · $695 in 2025
The $695 reported for 2025 was more than what 87% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $479 · 2020: $304 · 2021: $554 · 2022: $752 · 2023: $658 · 2024: $524 · 2025: $695.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,735 · Education: $141.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,735.34 |
| Education | $140.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $743.66 | 2019-2024 | Lo Loestrin Fe, Orilissa |
| Astellas Pharma US INC | $499.69 | 2019-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $364.85 | 2023-2025 | Myfembree, Gemtesa |
| Novo Nordisk INC | $294.55 | 2019-2025 | Wegovy, Saxenda |
| Mayne Pharma Commercial LLC | $238.50 | 2021-2025 | |
| Pfizer INC. | $219.94 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $200.51 | 2019-2023 | |
| Exeltis, USA INC. | $171.03 | 2020-2025 | Slynd |
| Daiichi Sankyo INC. | $142.52 | 2020-2023 | Injectafer |
| Hologic Sales and Service, LLC | $112.99 | 2019-2024 | Thinprep 2000 Processor, Myosure Tissue Removal Device |
| Organon LLC | $96.41 | 2022-2025 | Nexplanon |
| Millicent US INC | $95.71 | 2019-2025 | Intrarosa, Femlyv |
| Agile Therapeutics, INC. | $79.47 | 2021-2023 | Twirla |
| Dysis Medical, INC. | $76.48 | 2022 | |
| Therapeuticsmd, INC. | $76.13 | 2019-2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $57.42 | 2025 | Zurzuvae |
| Amag Pharmaceuticals, INC. | $54.49 | 2019-2020 | |
| Mylan Pharmaceuticals INC. | $47.89 | 2021-2022 | |
| Amgen INC. | $47.64 | 2019-2025 | Evenity, Prolia |
| Myovant Sciences INC. | $43.97 | 2021-2022 | |
| Convatec INC. | $33.86 | 2023-2025 | |
| Channel Medsystems, INC. | $25.23 | 2024-2025 | |
| Evofem Biosciences, INC. | $24.53 | 2023 | Phexxi |
| Allergan, INC. | $22.77 | 2019 | |
| Axonics, INC. | $22.73 | 2023 | Axonics |
| Ethicon US, LLC | $20.67 | 2024 | Enseal X1, Ethicon |
| Lupin INC. | $20.21 | 2019 | |
| Conmed Corporation | $18.65 | 2025 | Airseal |
| Coloplast Corp | $17.34 | 2025 | |
| Medtronic, INC. | $16.21 | 2022 | |
| Merck Sharp & Dohme LLC | $16.13 | 2021 | |
| Avanos Medical | $14.14 | 2021 | |
| Coopersurgical, INC. | $13.71 | 2020 | |
| Glaxosmithkline, LLC. | $13.43 | 2021 | |
| Avion Pharmaceuticals | $12.06 | 2019 | |
| Meditrina | $9.53 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patricia Brands listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.